Revelation Biosciences Warrant
REVBW
13 hedge funds and large institutions have $9.99K invested in Revelation Biosciences Warrant in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 0 closing their positions.
50% more capital invested
Capital invested by funds: $6.66K → $9.99K (+$3.33K)
18% more funds holding
Funds holding: 11 → 13 (+2)
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$525 |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$440 |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$31 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIA
Soltis Investment Advisors
St. George,
Utah
|
-$260 |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$142 |
| 3 |
PVI
Pine Valley Investments
Marlton,
New Jersey
|
-$89 |
| 4 |
CS
Clear Street
New York
|
-$6 |
| 5 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$5 |
REVBW Hedge Fund Activity: Q2 2026 in Review
13 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q2 2026, worth a combined $9.99K — up 50% from $6.66K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new REVBW positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 6 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $525. The largest seller was Soltis Investment Advisors, cutting an estimated $260.
- 13 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q2 2026, up from 11 in Q1 2026.
- Funds reported $9.99K of Revelation Biosciences Warrant stock for Q2 2026, up 50% quarter-over-quarter.
- 2 funds opened new Revelation Biosciences Warrant positions in Q2 2026 and 0 closed out, a net change of +2 holders.
- The largest Revelation Biosciences Warrant buyer in Q2 2026 was Virtu Financial, an estimated $525 added.
- The largest Revelation Biosciences Warrant seller in Q2 2026 was Soltis Investment Advisors, an estimated $260 sold.
Based on aggregated 13F filings for Q2 2026.